UiPath (NASDAQ:PATH) Issues Earnings Results

UiPath (NASDAQ:PATH) released its earnings results on Monday. The healthcare company reported $0.02 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.07, Fidelity Earnings reports.

NASDAQ PATH traded down $3.35 during midday trading on Wednesday, hitting $72.65. The company had a trading volume of 118,168 shares, compared to its average volume of 2,547,406. The stock has a fifty day moving average of $54.63. UiPath has a fifty-two week low of $61.50 and a fifty-two week high of $90.00.

Several research analysts have recently commented on the stock. Wolfe Research assumed coverage on shares of UiPath in a research note on Monday, May 17th. They set a “peer perform” rating and a $70.00 price target on the stock. Macquarie assumed coverage on shares of UiPath in a research note on Monday, May 17th. They set a “neutral” rating and a $69.00 price target on the stock. Wells Fargo & Company assumed coverage on shares of UiPath in a research note on Monday, May 17th. They set an “equal weight” rating and a $75.00 price target on the stock. JPMorgan Chase & Co. assumed coverage on shares of UiPath in a research note on Monday, May 17th. They set a “neutral” rating and a $68.00 price target on the stock. Finally, Canaccord Genuity restated a “hold” rating and set a $75.00 price target (up previously from $70.00) on shares of UiPath in a research note on Wednesday. They noted that the move was a valuation call. Eleven analysts have rated the stock with a hold rating and eight have given a buy rating to the company. UiPath currently has a consensus rating of “Hold” and an average target price of $76.89.

In other news, major shareholder East Fund 2013 Sca Sic Digital sold 2,100,400 shares of the firm’s stock in a transaction dated Friday, April 23rd. The shares were sold at an average price of $56.00, for a total transaction of $117,622,400.00. Also, CEO Daniel Dines sold 1,383,168 shares of the firm’s stock in a transaction dated Friday, April 23rd. The stock was sold at an average price of $56.00, for a total transaction of $77,457,408.00. Insiders have sold a total of 5,011,241 shares of company stock valued at $280,629,496 over the last ninety days.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. It develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities, such as robust debugging tools, application programming interface automation, wizards to automate desktop or web applications, leverage custom code, and to integrate machine learning models into production workflows.

Read More: How is inflation measured?

Earnings History for UiPath (NASDAQ:PATH)

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.